Based on data collected from different sources by our team,
there are indicators that suggest that this company is no longer active. However, this information may not be accurate.
If you believe this information should be updated, please .
For more details, you can read our .
10/2022 due to acquisition
NitiLoop
NitiLoop Overview
Nitiloop has developed the NovaCross, a microcatheter that enables guidewire positioning and distal support, with an extendable segment for additional support. The NovaCross, comprising a competent supporting microcatheter and a low-profile microcatheter, uses an operator-controlled nitinol scaffold and an extendable segment, both at its distal tip.
The proprietary platform used in the NovaCross is also used as a basis for additional products intended for below-the-knee and embolotherapy applications, the treatment of liver cancer with chemotherapy, and the injection of radiation beads through the microcatheter.
NitiLoop Climate Tech relevance
undefined
Companies you might be interested in
Driven by Finder AI
Latest News
No Data, yet.
Sorry, no content found under this section.
Oct 10, 2022
cardiovascularbusiness.com
Microbot Medical acquires Nitiloop's assets, including FDA-cleared microcatheters
#Acquisition
Apr 7, 2020
www.prnewswire.com
Nitiloop's NovaCross Earns FDA Clearance for Treating Chronic Total Occlusion (CTO) Prior to PTCA or Stent Intervention
#Investment
Oct 26, 2017
www.prnewswire.com
Nitiloop Announces FDA 510(k) Clearance for its Nova Cross Extreme and Nova Cross BTK Micro catheter for Support of Guidewire Access to Discrete Regions of the Coronary and Peripheral Vasculature
#Customers
May 18, 2015
www.businesswire.com
Nitiloop Announces FDA 510(k) Clearance for its NovaCross™ Microcatheter for Support of Guidewire Access to Discrete Regions of the Coronary and Peripheral Vasculature
Microbot Medical acquires Nitiloop's assets, including FDA-cleared microcatheters
#Acquisition
Apr 7, 2020
www.prnewswire.com
Nitiloop's NovaCross Earns FDA Clearance for Treating Chronic Total Occlusion (CTO) Prior to PTCA or Stent Intervention
#Investment
Oct 26, 2017
www.prnewswire.com
Nitiloop Announces FDA 510(k) Clearance for its Nova Cross Extreme and Nova Cross BTK Micro catheter for Support of Guidewire Access to Discrete Regions of the Coronary and Peripheral Vasculature
#Customers
May 18, 2015
www.businesswire.com
Nitiloop Announces FDA 510(k) Clearance for its NovaCross™ Microcatheter for Support of Guidewire Access to Discrete Regions of the Coronary and Peripheral Vasculature
undefined
View other companies you might be interested in
NitiLoop Team
No Data, yet.
Sorry, no content found under this section.
View other companies you might be interested in
Connect with
What is the reason for connecting? *
Your company *
Company website (recommended)
Please enter a valid website
Your organization type *
Please enter a valid organization type
Your position *
Add invitation message
0/300
Sending invitation...
Invitation sent
You will be able to start a conversation once [Name] accepts it.